Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians | Synapse
March 5, 2026
Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians
Key Points
This review aims to evaluate the efficacy and comparative effectiveness of respiratory syncytial virus vaccines in adults who are not pregnant or immunocompromised.
Conducted a rapid review to gather existing data on vaccine efficacy
Focused on adult populations who are not pregnant or immunocompromised
Reviewed comparative effectiveness against other respiratory viruses
Identified varying levels of efficacy among different vaccine candidates
Highlighted potential safety concerns for certain vaccine options
Found evidence suggesting improved outcomes in vaccinated adults
Abstract
American College of Physicians. (PROSPERO: CRD420251145237).